NODAL and breast carcinoma: Hendrix and colleagues [11,12] have shown that expression of Nodal in metastatic melanomas and breast carcinomas is correlated with cancer progression, whereas pathway inhibition decreases cell invasiveness, colony formation and tumourigenicity.